Vista Watchlist Stock Chinook Therapeutics Acquired For ~$3.5B While Stocks Advance On Monday – $AAPL $KDNY $LTRN $TSLA $VIX Rise!
Happy Monday!
I hope that went well for all of you today.
This was a great day for many of us as a company that has been part of our VP Watchlist and simultaneously presented with our sister organization Tribe Public www.tribepublic.com over the last three years, Chinook Therapeutics (KDNY, $37.98, +58.32%), a clinical-stage biopharmaceutical company developing precision medicines for kidney disease, was bought out today by Novartis (NVS) for approximately $3.5B, a significantly higher multiple than when we discovered it. Specifically, Novartis has agreed to acquire Chinook for $40 per share in cash, with potential to receive up to an additional $4 per share in cash through contingent value rights, for a total equity value of up to approximately $3.5 billion. Chinook’s diversified pipeline of potentially best-in-class programs for rare, severe chronic kidney diseases will significantly expand the Novartis renal portfolio, complementing its existing pipeline. The transaction is expected to be completed in the second half of 2023, subject to customary closing conditions
As for the broad markets, equites overall advanced across the board on Monday as we await Tuesday’s reveal of May’s Consumer Price Index (CPI) or inflation reading followed by the Fed’s interest rate decision on Wednesday. However today, just one macroeconomic report hit the tape as The May Treasury Budget report confirmed a significantly larger deficit of $240.3B compared to a year ago. As a result, the US yield curve settled as the 2-yr yield closed at 4.59% & the 10-yr yield closed at 3.77%. The U.S. Dollar Index also closed at 103.63, +.07%. Crude Oil prices closed $67.38/bbl, +.39%.
The S&P 500 closed at 4,338.93 (+.93%) as the information technology sector’s 2.1% jump was the top mover, the influential consumer discretionary sector rose by 1.7%, & the communication services sector added 1.2%. The heavily-weighted technology giant Apple (AAPL) closed at $183.79, +1.56%. On June 5, Apple unveiled Apple Vision Pro™, a revolutionary spatial computer that seamlessly blends digital content with the physical world, while allowing users to stay present and connected to others. EV-maker Tesla (TSLA) rose again and now for the 12th consecutive trading session to close at $249.83, +2.22% & is now up an attractive 102.82% YTD. Elon Musk has pushed further back up in the $200B club and is he is now back to being the world’s richest man. Again it is good to be Elon!
The Dow 30 closed back above the 34k market at 34,066.33 (+.56%). Disney (DIS, $93.14,+1.32%). On June 12, Disney honored World War II female U.S. Navy veteran Dorothy “Pat” Rudd as “Veteran of the Day” during the June 7th Flag Retreat ceremony in Magic Kingdom at Walt Disney World. A pioneer and heroine, Pat volunteered and joined the Women Accepted for Volunteer Emergency Service (WAVES) program to perform shore-based duties for the U.S. Navy after U.S. President Franklin D. Roosevelt signed Public Law 689 in 1942.
The Nasdaq closed at 13,461.92 (+1.53%), while Cathie Wood’s ARK Innovation ETF (ARKK) closed at $43.28, +1.81%. NVIDIA Corporation (NVDA) added 1.84% to close at $394.82. Intel Corporation (INTC) closed at $33.07, (+5.52%).
The growth oriented small caps closed up today as the Russell 2000 closed at 1,873.21 (+.40%), as did the MicroCaps as the Micro-cap ETF (IWC) closed at 110.80,+.71%.
Banks stocks retraced a bit after this week’s surge as The SPDR S&P Regional Banking ETF (KRE) fell .74% to close at $43.14 & the SPDR S&P Bank ETF (KBE) moved lower by .77% to close at $37.26.
Biotech stocks moved nicely higher as the SPDR S&P Biotech ETF (XBI) closed at $88.61, +1.08%. The 52-wk range is $62.13 – $95.18. The iShares Biotechnology ETF (IBB) edged higher to close at $129.87,+.80%. The 52-range is $104.29 – $138.74.
Today, Lantern Pharma Inc. (NASDAQ: LTRN, $5.83, +7.96%), a clinical-stage biopharmaceutical company using its proprietary RADR® artificial intelligence (“AI”) and machine learning (“ML”) platform to transform the cost, pace, and timeline of oncology drug discovery and development, announced that the U.S. Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for LP-184, which is being developed for multiple advanced solid tumors and central nervous system (CNS) cancers. The first-in-human Phase 1A trial for LP-184 is anticipated to launch and dose its first patient during the current quarter. LP-184 is a novel, synthetically-lethal, small molecule that has been developed using insights from Lantern’s AI platform, RADR®. Lantern has been granted multiple Orphan Drug Designations by the FDA for LP-184 in pancreatic cancer, malignant gliomas, and atypical teratoid rhabdoid tumors (ATRT); in addition the FDA granted Rare Pediatric Disease Designation granted for LP-184 in ATRT. The cancer indications being pursued for LP-184 are estimated to have an annual market potential of $11-13 billion; $6-7 billion for solid tumors and $5-6 billion for brain and CNS cancers.
On June 8, Lantern announced it will be leveraging its AI platform, RADR®, in a research collaboration with Bielefeld University (Bielefeld, Germany) to develop antibody-drug conjugates (ADCs) with high therapeutic and antitumor potential. The collaboration will leverage insights from Lantern’s recently developed RADR® AI ADC module in combination with research from Professor Norbert Sewald, Ph.D., the principal investigator for Bielefeld and leader of Magicbullet::reloaded, a European consortium focused on developing novel drug delivery mechanisms, including ADCs. Outcomes from the collaboration are expected to pave the way for next-generation ADCs and other drug conjugates that are designed using AI and that can be developed with potentially higher efficacy, at a faster pace, and with significantly reduced costs. The collaboration with Bielefeld University (Germany) will be led by Professor Norbert Sewald, Ph.D., a leading expert in the synthesis of cryptophycins, development of ADCs, and the coordinator of the “Magicbullet::reloaded” consortium. Lantern is receiving an exclusive and worldwide option to license intellectual property from Bielefeld University related to the collaboration and IP generated from the collaboration. The global ADC market is currently over $4.0 billion and is projected to reach $14.0 billion by 2027.
The iShares U.S. Healthcare ETF (IYH) closed at $275.33, +.54%.
Around the crypto and precious metals’ tree, Bitcoin (BTC) traded to $25,929.55, +.02% over the last 24 hours at the time of this writing. Gold prices closed still below 2k at $1,964, -$3/oz. & silver closed at $24.13, -$.23/oz. on the day. Two mining producers closed the day as follows: Hecla Mining Company (HL) closed at $5.29, -.94% & First Majestic (AG, $5.70, -.70%). Recently, Hecla provided an update on forest fires in Abitibi and the Eeyou-Istchee region in the James Bay area affecting the Casa Berardi operations. Quebec’s Ministry of Natural Resources and Forests announced the closure of forest lands and certain roads, which include the access road to the Casa Berardi mine site. The Company has suspended operations at the Casa Berardi mine temporarily. All mine personnel are safe, and the infrastructure has not been impacted. The Company continues to comply with the directives of the Ministry and is in close contact with the authorities.
The CBOE Volatility Index (^VIX) closed at $15.01,+8.53%.
FURTHER AFIELD
Shares of Carvana Co. (CVNA), the leading e-commerce platform for buying and selling used cars, rose to close at $21.26 +11.48%. Last week, Carvana management provided an improved Q2 2023 outlook based on even stronger anticipated results from its continued plan to drive profitability and expects to achieve Adjusted EBITDA above $50M and Total Gross Profit Per Unit above $6,000 in Q2 2023.
Shares of C3.ai, Inc. (NYSE: AI), the Enterprise AI application software company, moved up to close at $37.60, +1.65%. On May 31, AI announced financial results for its fiscal fourth quarter and full fiscal year ended April 30, 2023. Highlighting Total revenue for the quarter was $72.4 million.
Shares of ADT Inc. (ADT), the most trusted brand in smart home and small business security, closed at $6.20,+1.81%. On May 2, ADT reported results for the first quarter of 2023 highlighting strong year-over-year growth in revenue; CSB and Commercial up 7% and 15%, respectively, versus prior year period, maintained record high customer retention and new record high recurring monthly revenue balance, improved capital efficiency with record revenue payback, & continued deleveraging with over $400 million debt reduction expected in 2023.
Shares of Seanergy Maritime Holdings Corp. (SHIP), the only pure-play Capesize ship-owner publicly listed in the US. closed at $4.19, -3.46%. On May 25, SHIP announced its financial results for the first quarter ended March 31, 2023, and declared a quarterly dividend of $.025 per share for the first quarter of 2023. They highlighted the following: Quarterly cash dividend of $0.025 per share for Q1 2023 – resulting in total cash dividends of $1.30 per share or $23.4 million declared since March 2022, in addition to the spin-off and distribution of shares of United Maritime Corporation in July 2022, New financing and refinancing transactions of $53.8 million on improved terms adding approx. $15.0 million of extra liquidity, Elimination of 92% of the original $38.7 million convertible note, following the $8.0 million repayment in Q1 2023. $0.85 million open market common shares purchases by Seanergy’s management. & Repurchased 47% of the outstanding Class E Warrants through a tender offer.
MEMES CENTRAL
Memes stock GameStop Corp. (GME) closed at $24.30, +7.14% as the shorts lost the ongoing daily battle decidedly today after reports surfaced that 2 directors purchased shares. Last week, GameStop move to fire its CEO Matt Furlong & appointed board chair/activist investor Ryan Cohen to lead. On June 1, The Telos Foundation announced a strategic collaboration with GameStop that will allow the Telos blockchain to access mainstream gaming distribution via GameStop’s upcoming Web3 game launcher, GameStop Playr. This collaboration signifies a meaningful opportunity to expand the global GameFi ecosystem and bring Web3 gaming to mainstream users. The collaboration will enable users to enjoy Web3 games supported by Telos, which is a decentralized blockchain with proven scalability, affordability, low carbon footprint, and impressive lifetime track record of continuous uptime.
Shares of AMC, the largest movie exhibition company in the United States, the largest in Europe and the largest throughout the world with approximately 950 theaters and 10,500 screens across the globe, closed at $4.79, +.42% and APE closed at $1.59, +.63%. AMC reported results for the first quarter ended March 31, 2023 on May 5 highlighted by total revenue growth of 21.5% to $954.4 million & a net loss improved by $101.9 million to $235.5 million.
Recently, our sister organization Tribe Public co-hosted three CEO Presentation and Q&A events in the greater Phoenix area with Panna Sharma, CEO of Lantern Pharma (NASDAQ: LTRN, $5.83, +7.96% and peppered briefly up to $6.09 in the aftermarket today), an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Their proprietary AI and machine learning (ML) platform, RADR®, leverages over 25 billion oncology-focused data points and a library of 200+ advanced ML algorithms to help solve billion-dollar, real-world problems in oncology drug development. By harnessing the power of AI and with input from world-class scientific advisors and collaborators, they have accelerated the development of our growing pipeline of therapies including eleven cancer indications and an antibody-drug conjugate (ADC) program. On average, their newly developed drug programs have been advanced from initial AI insights to first-in-human clinical trials in 2-3 years and at approximately $1.0-2.0 million per program. Lantern is targeting the $200 Billion current global oncology drug market.
Chief Executive Officer, President and Director Panna Sharma
Learn more about Lantern at their website https://www.lanternpharma.com.
The multi-billion-dollar global fertility market is predicted to reach approximately US$47.9 billion by 2030, yet remains severely underserved with many patients (upwards of 90% by many estimates) unable to access affordable treatment. INVO Bioscience, Inc. (NASDAQ: INVO, $.1925 offers the INVOcell solution which provides an advanced, effective and affordable infertility treatment to help increase access to care. INVO is commercially advancing INVOcell through the opening of INVO Centers, opportunistically now pursuing acquisitions of established fertility (IVF) clinics in the U.S., and continuing to offer the technology to existing fertility practices.
On May 15, INVO announced financial results for the quarter ended March 31, 2023 and provided a business update. Steve Shum, CEO of INVO stated, “We made significant progress on nearly every key operational metric during the first quarter, particularly within our three existing INVO Centers in Atlanta, Birmingham and Monterrey achieving record levels of revenue and patient cycles. These three centers combined to generate $646,707 in revenue, an increase of 108% from the first quarter of the prior year and were ahead 46% sequentially from Q4 2022, as patients increasingly recognize and value the remarkable opportunity INVO offers to assist families with affordable fertility options. We are extremely pleased to see the existing clinics nearing break-even and look forward to each of them generating positive cashflows and profits in the near future. Tampa Fertility Institute, our planned INVO Center in Tampa, is progressing with a mid-summer target opening and we are also executing on the early preparation work for an INVO Center in Kansas City. To build on the success we are achieving with our INVO Centers, we expanded our commercialization approach to include the acquisition of established and profitable US IVF clinics and announced the execution of binding agreements to acquire Wisconsin Fertility Institute,” Shum continued. “We view our acquisition strategy as highly complementary to our ongoing efforts to build new INVO Centers, increase sales of our INVOcell® device and expand adoption of the IVC procedure. We expect this strategy to accelerate our corporate development efforts and our path to profitability, as we integrate IVC alongside IVF. We view these two procedures as highly complementary to each other and to our mission of expanding access and affordability for the millions of people for whom the cost of IVF is out of reach. We look forward to closing the acquisition in the current quarter.”
On April 18, Maxim Group’s Analyst Jason McCarthy, Ph.D. issued a BUY rating on INVO Bioscience (INVO). His report is titled, “4Q Results and Outlook: Fertility Space Remains Active as INVO Expands Strategy with IVF Clinic Acquisition.” His 12-month Price Target is $3.
On April 5, INVO announced that it congratulates recently acquires Wisconsin Fertility Institute on being named one of America’s Best Fertility Clinics by Newsweek. During the survey period from November to December 2022, Newsweek and Statista invited over 3,000 reproductive endocrinologists, infertility specialists, obstetricians/gynecologists working in and referring patients to fertility clinics, other medical professionals (e.g., registered nurses, laboratory assistants) and fertility clinic administrators/managers working in fertility clinics to participate in the survey. Participants were asked to assess the quality in five categories for each recommended facility and to assign a ranking position to a set of fertility clinics. Only facilities defined as fertility clinics and ART (“Advanced Reproductive Technology”) providers by the Centers for Disease Control and Prevention (CDC) were considered. Click here for a full listing and methodology for inclusion.
On March 27, INVO Bioscience announced the closing of its previously announced registered direct offering of 3,680,000 shares of common stock (or pre-funded warrants in lieu thereof), priced at-the-market under Nasdaq rules. In a concurrent private placement, the Company also issued warrants to purchase up to an aggregate of 5,520,000 shares of common stock. The combined effective offering price for each share of common stock (or pre-funded warrant in lieu thereof) and warrant is $.815. The warrants are immediately exercisable, expire on the eight-year anniversary of the issuance date and have an exercise price of $0.63 per share. Maxim Group LLC is acting as the sole placement agent for the offering.
On Jan. 16, BioSpectrum published an article titled “INVO Bioscience introduces next-gen technologies to fertility market in Taiwan.”
On Jan. 5, INVO Bioscience announced it has entered an exclusive distribution agreement with Ming Mei Technology Co. Ltd (“Ming Mei”) for Taiwan. The agreement will have an initial 1-year term with renewals. Ming Mei is a leading distributor of fertility-based devices and components in Taiwan helping to bring the latest and most advanced medical equipment into the region. Ming Mei estimates it has approximately 90% coverage of reagents and consumables in the reproductive medicine market in Taiwan. With strong customer relationships in the region, and their familiarity with the field of reproductive medicine, Ming Mei is ideally suited to expand distribution of INVOcell in Taiwan. Taiwan is a destination for assisted reproductive technology (ART) throughout Asia and also has the lowest birthrate in the world. Taiwan’s birth rate has dropped as a result of similar trends elsewhere in Asia, such as later marriage and increasing cost of living. Further, the average age of patients requiring therapy is rising. Fortunately, according to the statistics published by “ICMART”, the overall implantation rate of therapy in Taiwan ranked second worldwide, almost equal to the level in the U.S., and a leading country in Asia. The stable high success rate derives from updated medical research and enriched clinical experience from the physicians, advanced laboratory facilities and technology as well as patient-centered customized treatment plans (depending on their age, ovarian functions and causes of infertility, etc.) Prior to the pandemic, in 2019 there were approximately 55,000 ART cases in Taiwan, an increase of approximately 55% compared to 2016. In July 2021, the government in Taiwan implemented a subsidy plan for ART with the goal of encouraging more local married couples to undergo ART treatments. The subsidies are also available to transnational couples in which one spouse holds a Taiwanese ID card.
On Jan. 3, INVO announced it has signed an agreement with Shelly W. Holmström, M.D. FACOG, to serve as the physician operator for the Company’s soon to be opened Tampa, Florida INVO Center.
Today, shares of Borqs Technologies, Inc. (Nasdaq: BRQS) closed at $.2015, -.84%. The 52-week range is $.1930 – $4.688.
-
On June 7, Borqs announced that The Nasdaq Stock Market LLC has provided written notice dated June 2, 2023, that the Company is eligible for an extension until October 24, 2023, to regain compliance with Nasdaq’s minimum $1 bid price requirement, as set forth in Nasdaq’s Listing Rule 5550(a)(2) (the “Bid Price Rule”). The Company has explained to the Nasdaq Panel that the sale of our solar subsidiary, Holu Hou Energy LLC (“HHE”) may bring forth a significant liquidity position and can positively affect our stock price.“The Company believes that since HHE has several hundred million dollars of PPA contract bookings, the sale of our equity in HHE may generate a significant amount of cash for the Company,” said Pat Chan, the Company’s CEO. The Company has provided written notice, as required by Nasdaq, of our intention to cure the deficiency during the period by the sale of our subsidiary and also by effecting a reverse stock split, if necessary. Compliance can be attained during this additional time period if the closing bid price of the Company’s security is at least $1 per share for a minimum of 10 consecutive business days before October 24, 2023.
- On May 15, Borqs reported revenues for the year ended December 31, 2022 increased 77.7% to $52.5 million compared to $29.6 million for the year ended December 31, 2021, mainly driven by increased IoT hardware sales globally and software service revenues from a global semiconductor vendor.
-
On May 9, Borqs announced that they have engaged Cantor Fitzgerald & Co. as its exclusive financial advisor with respect to the divestment of the Company’s ownership in Holu Hou Energy, LLC (“HHE”), a fast-growing solar energy and storage provider with unique solutions in energy sharing for the multi-dwelling residential market. Cantor Fitzgerald will conduct a sales process on behalf of Borqs with respect to its divestment in HHE and has commenced outreach to potential acquirers in May 2023. Please direct any questions regarding this sales process or prospective interest to: Hari Chandra Managing Director, Global Head of Power, Energy and Infrastructure, Cantor Fitzgerald & Co., Phone: +1 (347) 268 8636, Email: hari.chandra@cantor.com.
HHE’s unique and proprietary solar energy storage system harnesses the power from solar panels, stores that energy, and has the capability to share it among multiple residential or commercial units thus providing a new level of resilience to homeowners, apartment owners, and businesses, providing energy security in uncertain and unstable times. HHE has signed multiple contracts with customers in Hawaii for the deployment of HHE’s solar energy plus storage system and EnergyShare technology for Multi-Dwelling Residential Units such as the recently announced Lendlease Island Palm Communities in Honolulu for large military personnel housing communities. Installations for these projects are to begin this summer. As previously disclosed, Borqs is mandated by the Committee on Foreign Investment in the United States (“CFIUS”) to divest its interests in HHE due to risks to national security arising as a result of Borqs’s investment in HHE. www.holuhou.com.
- On April 26, Borqs Technologies published its Letter to Shareholders Regarding the Divestment of Solar Subsidiary. Dear Shareholders of Borqs Technologies, Inc.: The purpose of this letter is to help clarify the proposed divestment of our company’s ownership in Holu Hou Energy, LLC (“HHE”) and the implications that this transaction may have to Borqs and our shareholders. Why the divestment? As we have stated in prior press releases, the Committee on Foreign Investment in the United States (“CFIUS”) has notified our company by a letter dated December 13, 2022, that CFIUS has identified risks to US national security arising as a result of Borqs’s investment in HHE. CFIUS advised us that the national security risks arising as a result of Borqs’s investment transaction with HHE relate to foreign proximity to U.S. military personnel and installations through HHE’s physical access to customers and their facilities, including at off-base military housing. CFIUS therefore required Borqs and HHE to enter into a National Security Agreement with CFIUS, pursuant to which Borqs must divest its interests in HHE. Proactive steps by Borqs. Read the balance here:
-
On April 20, Borqs announced that its subsidiary, Holu Hou Energy LLC (HHE), a provider of design-to-service solar plus energy storage systems, has signed a contract to install HHE’s HoluPower energy storage and solar photovoltaic (PV) systems on homes at Lendlease’s Island Palm Communities (IPC) in Honolulu, Hawaii. When completed, the project will be worth well into the nine figures in sales for HHE. Lendlease, a leading real estate and investment group that manages almost 8,000 homes for the U.S. Army on Oahu, is the purchaser of the electricity and the installations will come in the form of HHE’s EnergyCluster, where multiple residential units have their systems connected in an energy network or “cluster.” Excess solar generation from any unit’s system in the network that would normally be lost is directly shared in real time with other connected units that have load above solar generation. The benefit is that the optimized PV and energy storage systems can meet 75-80% or more of the overall residents’ energy needs while not exporting power to the utility grid. Lendlease and HHE began initial planning in 2021, which culminated in constructing a “pilot” project in May 2022. Since then, the pilot has been operating with outstanding results across six residential units. In a typical month, approximately a third of the total generated electricity is shared with other units in the “cluster” thereby solving issues related to vacancy and resident load variability, while proving out the superior value created through a clustered approach versus stand-alone systems. The savings realized by Island Palm Communities through deployment of HHE’s systems is being reinvested to enhance the housing and amenities Lendlease offers to military families on the installation. Additionally, residents now have resilient back-up power that can be utilized during grid outage events. These systems also take a load burden off the Oahu electric grid, which improves overall stability. Each residential unit will have approximately 10kW of PV and 25 kWh of energy storage, with six residences typically being connected in an HHE EnergyShare network. Construction is set to begin summer of 2023, with initial installations at the Aliamanu Military Reservation near Honolulu.
-
On March 23, Borqs announced that the Company has appointed Donald R. Kendall, Jr. as the sole trustee (the “Trustee”) to a divestment trust established to manage the orderly divestment of Borqs’ ownership of Holu Hou Energy, LLC, (“HHE”) as required by the Committee on Foreign Investment in the United States (“CFIUS”). Mr. Kendall has an extensive background of over four decades in investment management, including his role as the Chairperson of the Special Committee of the Board of Directors of SolarCity supervising the sale of SolarCity to Tesla, Inc. in 2016 for $2.6 billion. Mr. Kendall currently serves as the Managing Director and CEO of Kenmont Capital Partners, LP, an investment management firm with an emphasis on energy, alternative energy and transportation and General Partner of New Climate Ventures, an early-stage venture capital fund that invests in innovative early-stage startups with a focus on carbon avoidance and reduction. Mr. Kendall currently serves on the board of Talos Energy Inc. and has served on the boards of SolarCity Corporation, American Midstream Partners, LP, Stream Gas & Electric, Ltd., and Syzygy Plasmonics Inc. “We’re very excited and honored to have Don accepting the appointment to head up the sale of our solar subsidiary. HHE has been growing its share in the Hawaiian solar market significantly since Borqs’ acquisition in October 2021. We believe HHE’s unique EnergyShare solution also has tremendous potential in California and the other parts of the U.S. With Don’s vast experiences in the energy industry, I have no doubt that he will be able to orchestrate a successful divestment for us and find a suitable partner for HHE, while adhering to all applicable CFIUS requirements. We expect to generate a considerable liquidity position for the Company from the sale which will directly contribute to Borqs’ shareholder value,” stated Mr. Pat Chan, CEO of Borqs.
-
On March 13, Borqs announced that the Company has entered into the two/three-wheelers automotive space by developing the smart cluster dashboard and has successfully demonstrated the newly developed unit during the 2023 January CES Exhibition. The new smart cluster dashboard is installed on a two-wheeler and connected to the internet via the cellular network. The Company is partnering with Faspro Systems who will assist Borqs in sales and also support deployment in the region. As of October 2022, there are 14.38 million motorcycles and 8.43 million cars registered in Taiwan. That is, about 62 percent of Taiwanese 23.19 million population currently own a scooter. Full Year 2022 sales have been 752,631 units. The electric vehicle segment is growing moderately. he smart cluster dashboard, developed by Borqs’ design team, supports global cellular bands, dual-band Wifi and GPS. The unit enables the connected 2-wheeler to provide mobile telephony, data connectivity, vehicle diagnostics, location services, remote vehicle control, battery management, and sensing capabilities. Through a companion application on a smart phone, a user can locate and control the 2-wheeler, locate near-by charging/gas stations, etc. Connected to a cloud, a whole set of analytics and guidance can be provided to various stake holders. The smart cluster dashboard is modular in architecture and has ample I/Os for any custom design. Borqs having its core strength in development of cellular radios can support OEMs for system integration on the vehicles to get better connectivity
- On March 8, Borqs announced that the Company has won a contract with a prominent North American company to develop and manufacture an Android 5G rugged waterproof handheld device to be deployed in industries such as agriculture, oil and mining, utilities and safety, etc. The device will feature a long-life 5G chipset that can be used until 2030. The Company has signed multiple contracts with the same customer to develop a suite of enterprise class rugged devices which will be launched initially in the North American and European markets, to be followed by other countries.
- On March 6, Borqs announced its preliminary revenue for the year ended December 31, 2022 where the Company expects total revenue for the year ended December 31, 2022 to be $53-58 million, increased by over 79% compared to $29.6 million for the year ended December 31, 2021, driven by increased IoT sales globally and revenues from Holu Hou Energy (HHE), Borqs’ solar energy storage system subsidiary. Reportedly, while the revenue from Borqs’ IoT business is expected to be more than 80% of the total revenue, the HHE’s revenue has also increased significantly. The Company has not yet finalized its financial results for the full year ended December 31, 2022. These preliminary financial results reflect the company’s current estimates, based on information available to management as of the date of this release, and are subject to further changes upon completion of the company’s year-end closing and audit procedures.
Holu Hou Energy, LLC, a Delaware Corporation, brings state-of-the-art renewable energy and energy storage systems to the Single-Family Residential, Multi-Dwelling Unit Residential and Commercial building markets. With operations in California, Hawaii, Wisconsin and Shanghai, HHE engineers proprietary storage system and control platform solutions, including a breakthrough “HHE Energy Share” technology that is key to development of the Multi-Dwelling Unit Residential housing market. HHE is a vital partner for investors and asset owners that are seeking ESG solutions. For more information, visit www.holuhou.com.
On March 21, Atossa and Quantum Leap Healthcare Collaborative™ announced that Atossa’s proprietary Selective Estrogen Receptor Modulator (SERM), (Z)-endoxifen, will be evaluated in a new study arm of the ongoing I-SPY 2 clinical trial. The I-SPY 2 TRIAL evaluates neoadjuvant treatments for locally advanced breast cancer and is a collaborative effort among academic investigators from major cancer research centers across the United States, Quantum Leap Healthcare Collaborative, the U.S. Food and Drug Administration, and the Foundation for the National Institutes of Health (FNIH) Cancer Biomarkers Consortium. Approximately 20 patients will be treated with (Z)-endoxifen for up to 24 weeks prior to surgery.
Shares of InMed Pharmaceuticals Inc. (INM), a leader in the research, development and manufacturing of rare cannabinoids, closed at $1.28, -1.54%.
On June 1, InMed announced that results from a neurodegenerative disease study was presented in a scientific poster at the Canadian Neuroscience Meeting in Montreal from May 28-31, 2023. The InMed sponsored research, entitled “Cannabinoids modulate cytotoxicity and neuritogenesis in Amyloid-beta-treated neuronal cells”, demonstrated the ability of a specific rare cannabinoid (“pCBx”) in InMed’s 900 Series library of potential candidates that reduces amyloid toxicity and tau protein expression while enhancing neuronal cell growth and neuritogenesis markers in vitro, all considered to be important targets in the potential treatment of neurodegenerative diseases such as Alzheimer’s. The research was conducted in the laboratory of Dr. Ujendra Kumar and Dr. Rishi Somvanshi of the faculty of Pharmaceutical Sciences at the University of British Columbia. Studies have shown that cannabinoids, via their endocannabinoid receptors (CB1R and CB2R) that naturally occur in the human body and brain, reduce amyloid-beta (“Aβ”) toxicity, decrease p-tau protein expression and provide neurite outgrowth, thus improving neuronal viability and function. The results presented demonstrate the anti-apoptotic effects of pCBx and its role in neuritogenesis in the cells of neuronal origin and support the role of pCBx as a potential therapeutic intervention in neurodegenerative diseases.
On May 31, our sister organization, Tribe Public, hosted a Presentation & Q&A Webinar Event titled “InMed Pharmaceuticals (NASDAQ: INM) Addressing The Increasing Demand For Rare Cannabinoids.” The event was co-hosted by InMed Pharmaceutical’s (NASDAQ: INM) CEO Eric A. Adams, MIBS, & BayMedica’s Jerry P. Griffin, VP, Sales and Marketing. InMed Pharmaceuticals (NASDAQ: INM, $1.34, +6.35%) is a global leader in the development, manufacturing, and commercialization of rare cannabinoids, which is developing a pipeline of rare cannabinoid therapeutics and dedicated to delivering new treatment alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. i.e. Alzheimer’s Disease, Glaucoma, & a rare genetic skin disease, Epidermolysis Bullosa (EB). Together with its subsidiary, BayMedica LLC, the Company has unparalleled cannabinoid manufacturing capabilities to serve a spectrum of consumer markets, including pharmaceutical and health and wellness. If you missed this event, then you may now watch the event video at the Tribe Public YouTube Channel by clicking here.
Last week, I co-hosted 3 Tribe Public CEO & Presentation Luncheon Events in Newport Beach, CA, Slat lake City, CA and San Francisco, CA with Eric Adams CEO of InMed Pharmaceuticals (NASDAQ: INM), a pure-play rare cannabinoid company. The meetings were packed room & they received confirmation and understanding with regard to the 120% quarter-over-quarter revenue growth that InMed is enjoying in their commercial BayMedica subsidiary. Eric Adams recently stated, “In the last few months we have seen a noticeable increase in awareness, understanding and adoption of rare cannabinoids in the H&W sector, evidenced by leading companies expanding their product lines to include new formats and formulations using rare cannabinoids such as the non-psychoactive ingredient cannabichromene (“CBC”). We are encouraged by two consecutive periods of significant quarter over quarter revenue growth. We will continue to support growth in a fiscally prudent manner in this relatively nascent market, where product demand can be unpredictable. The combination of a pharmaceutical drug development pipeline, together with a revenue generating commercial operation that will be contributing to extending our cash runway makes InMed a unique company within the rare cannabinoid space.”
- On March 28, InMed announced it has concluded enrollment of its Phase 2 clinical trial using investigational drug INM-755 cannabinol (“CBN”) cream for the treatment of patients with epidermolysis bullosa (“EB”), a rare genetic skin disease. The Phase 2 study, called INM-755-201-EB, enrolled 19 patients. All four subtypes of inherited EB, including EB Simplex, Dystrophic EB, Junctional EB, and Kindler Syndrome were accepted into the trial. The clinical trial is evaluating the safety of INM-755 cannabinol cream and its preliminary efficacy in treating symptoms of itch, pain, and wound healing in patients with epidermolysis bullosa. The study used a within-patient, double-blind design whereby matched index areas are randomized to INM-755 (cannabinol) cream or vehicle cream as a control. Results from this Phase 2 study of INM-755 CBN cream are expected to be released early calendar Q3 2023. “Enrollment completion of this Phase 2 clinical trial of a cannabinol formulation represents an important milestone for InMed and the scientific community studying rare cannabinoids,” said Eric A. Adams, InMed’s President and CEO. “As a class of compounds, we believe cannabinoids hold tremendous therapeutic potential for their innate interaction with the body, however, to date there have been limited evidence-based studies investigating their effects. Taking a rare cannabinoid formulation through several Ph 1 and Ph 2 clinical trials has been a major undertaking. We look forward to the data read-out in the summer, so we can evaluate our strategic options and next steps.”
- On March 13, InMed announced that a peer-reviewed scientific study entitled “Rare phytocannabinoids exert anti-inflammatory effects on human keratinocytes via the endocannabinoid system and MAPK signalling pathway” has been published in the International Journal of Molecular Sciences.This is the second such Company-sponsored study to demonstrate the anti-inflammatory effects of rare cannabinoids and their potential application for the treatment of skin conditions such as atopic dermatitis, psoriasis, pruritus, and acne. The study, conducted in collaboration with Dr. Mauro Maccarrone at the Università degli Studi dell’Aquila, investigates the anti-inflammatory effects of the rare cannabinoids, cannabichromene (CBC), Δ9-tetrahydrocannabivarin (THCV), cannabigerol (CBG) and cannabigerolic acid (CBGA) on inflamed human keratinocytes (HaCaT cells) and elucidates the potential mechanism of action associated with these compounds in the skin.
Shares of Chinook Therapeutics, Inc. (KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, closed at $37.98, +58.32%.
Today, Chinook announced that it has entered into an agreement and plan of merger with Novartis AG pursuant to which Novartis will acquire Chinook for $40 per share in cash, or a total of $3.2 billion. This offer represents a premium of 83 percent to Chinook’s 60-day volume-weighted average stock price and 67 percent to Chinook’s closing price on June 9, 2023. In addition, Chinook shareholders will receive contingent value rights (CVRs) providing for payment of up to $4 per share upon the achievement of certain future regulatory milestones with respect to Chinook’s lead product candidate, atrasentan. Total consideration including the contingent value right, if the milestones are achieved, would be approximately $3.5 billion. The transaction has been unanimously approved by the Boards of Directors of both companies.
Today, Chinook also announced a focused oral presentation on zigakibart (BION-1301) will be presented on Friday, June 16, 2023 at the 60th ERA Congress being held virtually and live in Milan, Italy. “The strong data we will be presenting at the ERA Congress from the ongoing phase 1/2 study of zigakibart continue to demonstrate its disease-modifying potential in patients with IgAN,” said Eric Dobmeier, president and chief executive officer of Chinook Therapeutics. “In addition to sustained reductions in mechanistic biomarkers and correlating clinically meaningful proteinuria reductions observed in patients with IgAN with a wide range of baseline proteinuria levels, the phase 1/2 study has provided us additional key learnings that we look forward to implementing in the phase 3 BEYOND trial, including dose, schedule and route of administration and patient selection.”
On May 16, Chinook announced it has entered a collaboration agreement with Ionis Pharmaceuticals, Inc. for the discovery, development and commercialization of an antisense oligonucleotide (ASO) therapy for a rare, severe chronic kidney disease with significant unmet medical need. The companies will leverage Chinook’s precision medicine approach and deep expertise in nephrology and Ionis’ extensive expertise in RNA-targeted therapeutics.
On April 13, Chinook announced the appointment of Robert W. Azelby to its Board of Directors. Mr. Azelby brings more than 20 years of executive leadership and commercial experience in the biopharmaceutical industry to Chinook.“We are thrilled to welcome Bob to Chinook’s board of directors as we advance our pipeline through key milestones in 2023 and beyond,” said Eric Dobmeier, president and chief executive officer of Chinook Therapeutics. “Bob brings significant industry experience in building and growing companies and commercially launching new therapies, including in nephrology. His strategic counsel will be invaluable as we continue to advance treatments for patients with rare, severe chronic kidney diseases.” Mr. Azelby has more than two decades of experience leading biotech companies through key periods of development. Most recently, he served as president and chief executive officer of Eliem Therapeutics, a biotechnology company focused on developing novel therapies for neurology disorders, where he led the company through early growth with a $190 million in financing and a successful IPO. Previously, he served as the president and chief executive officer and a member of the board of directors of Alder BioPharmaceuticals, Inc. where he negotiated the successful sale of the company to Lundbeck. Prior to that, Mr. Azelby served as executive vice president and chief commercial officer of Juno Therapeutics through its acquisition by Celgene, and spent 15 years at Amgen in commercial roles across their nephrology and oncology business units. Mr. Azelby currently serves on the board of Clovis Oncology. He holds an M.B.A. from Harvard Business School and a B.A. in Economics and Religious Studies from the University of Virgin.
Economic Reports
On Monday, The May Treasury Budget report confirmed a significantly larger deficit of $240.3B compared to a year ago
Investing & Inspiration
- “I fear not the man who has practiced 10,000 kicks once, but I fear the man who has practiced one kick 10,000 times.” – Bruce Lee
- “There are no shortcuts in evolution.” – Louis D. Brandeis
- “Hope is the only bee that makes honey without flowers.” – Robert Green Ingersoll
- “Our happiness depends on wisdom all the way.” – Sophocles
- “Life is the art of drawing without an eraser.” – John W. Gardner
- “Give light and people will find the way.” – Ella Baker
- “Without craftsmanship, inspiration is a mere reed shaken in the wind.” – Johannes Brahms
- “Either move or be moved.” – Ezra Pound
- “Time is but the stream I go a-fishing in.” – Henry David Thoreau
- “It’s easy to make a buck. It’s a lot tougher to make a difference.” – Tom Brokaw
- “If you can’t stand the heat, get out of the kitchen.” – Harry S Truman
- “Remember upon the conduct of each depends the fate of all.” – Alexander the Great
- “Silence is the sleep that nourishes wisdom.” – Francis Bacon“
- “Have patience. All things are difficult before they become easy.” – Saadi
- “No man ever steps in the same river twice, for it’s not the same river and he’s not the same man.” – Heraclit
- “An effort made for the happiness of others lifts above ourselves.” – Lydia M. Child
- “It is amazing what you can accomplish if you do not care who gets the credit.” – Harry S Truman
- “If you do not think about your future, you cannot have one.” – John Galsworthy
- “Your own mind is a sacred enclosure into which nothing harmful can enter except by your permission.” – Arnold Bennett
- “There is always risk involved. You can’t be a capitalist only when there are investment profits but then a socialist when you experience losses.” – Cristina Kirchner
- “I hear, I know. I see, I remember. I do, I understand.” – Confucius
- “He has achieved success who has worked well, laughed often, and loved much.” – Elbert Hubbard
- “Nobody who ever gave his best regretted it.” – George Halas
- “We must not allow other people’s limited perceptions to define us.” – Virginia Satir
- “There is a wisdom of the head, and a wisdom of the heart.” – Charles Dickens
- “Perfection is the child of time.” – Joseph Hall
- “No matter what people tell you, words and ideas can change the world.” – Robin Williams
- “Find something you’re passionate about and keep tremendously interested in it.” – Julia Child
- “The glow of one warm thought is to me worth more than money.” – Thomas Jefferson
- “Between stimulus and response there is a space. In that space is our power to choose our response. In our response lies our growth and our freedom.” – Viktor E. Frankl
- “Progress lies not in enhancing what is, but in advancing toward what will be.” – Khalil Gibran
- “Cherish all your happy moments; they make a fine cushion for old age.” – Booth Tarkington
- “The most effective way to do it, is to do it.” – Amelia Earhart
- “If you’re going through hell, keep going.” – Winston Churchill
- “The only sure weapon against bad ideas is better ideas.” – Alfred Whitney Griswold
- “Words are, of course, the most powerful drug used by mankind.” – Rudyard Kipling
- “The more things change, the more they are the same.” – Alphonse Karr
- “Of all possessions a friend is the most precious.” – Herodotus
- “Everything has beauty, but not everyone sees it.” – Confucius
- “The man who is swimming against the stream knows the strength of it.” – Woodrow Wilson
- “Success is the sum of small efforts – repeated day in and day out.” – Robert Collier
- “You exist only in what you do.” – Federico Fellini
- “Most people have the will to win, few have the will to prepare to win.” – Bobby Knight
- “The true art of memory is the art of attention.” – Samuel Johnson
- The secret of happiness is something to do.” – John Burroughs
- “A will finds a way.” – Orison Swett Marden
- “To live is to think.” – Marcus Tullius Cicero
- “The sea hath fish for every man.” – William Camden
- “What is called genius is the abundance of life and health.” – Henry David Thoreau
- “Prosperity tries the fortunate, adversity the great.” – Rose Kennedy
- “No one can figure out your worth but you.” – Pearl Bailey
- “Let there be work, bread, water and salt for all.” – Nelson Mandela
- “When one paints an ideal, one does not need to limit one’s imagination.” – Ellen Key
- “Perfection is attained by slow degrees; it requires the hand of time.” – Voltaire
- “Time passes irrevocably.” – Virgil
- “The world of reality has its limits; the world of imagination is boundless.” – Jean-Jacques Rousseau
- “The time you enjoy wasting is not wasted time.” – Bertrand Russell
- “Mastering others is strength. Mastering yourself is true power.” – Lao Tzu
- “You begin with the possibilities of the material.” – Robert Rauschenberg
- “If you live to be a hundred, I want to live to be a hundred minus one day so I never have to live without you.” – A. A. Milne
- “The only way to discover the limits of the possible is to go beyond them into the impossible.” – Arthur C. Clarke
- “Do not dwell in the past, do not dream of the future, concentrate the mind on the present moment.” – Buddha
- “Curiosity will conquer fear even more than bravery will.” – James Stephens
- “There are years that ask questions and years that answer.” – Zora Neale Hurston
- “The best and most beautiful things in the world cannot be seen or even touched – they must be felt with the heart.” – Helen Keller
- “Every failure is a step to success.” – William Whewell
- “If you aren’t fired with enthusiasm, you will be fired with enthusiasm.” – Vince Lombardi
- “Either you run the day or the day runs you.” – Jim Rohn
- “A computer once beat me at chess, but it was no match for me at kick boxing.” – Emo Philips
- “I attribute my success to this – I never gave or took any excuse.” – Florence Nightingale
- “I can’t change the direction of the wind, but I can adjust my sails to always reach my destination.” – Jimmy Dean
- “If you fell down yesterday, stand up today.” – H. G. Wells
- “The world breaks everyone, and afterward, some are strong at the broken places.” – Ernest Hemingway
- “The quality, not the longevity, of one’s life is what is important.” – Martin Luther King, Jr.
- “You can’t expect to hit the jackpot if you don’t put a few nickels in the machine.” – Flip Wilson
- “Put your heart, mind, and soul into even your smallest acts. This is the secret of success.” – Swami Sivananda
- “If the highest aim of a captain were to preserve his ship, he would keep it in port forever.” – Thomas Aquinas
- “The secret of your future is hidden in your daily routine.” – Mike Murdock
- “Happiness is not a matter of intensity but of balance, order, rhythm and harmony.” – Thomas Merton
- “Seek the lofty by reading, hearing and seeing great work at some moment every day.” – Thornton Wilder
- “Once you bring life into the world, you must protect it. We must protect it by changing the world.” – Elie Wiesel
- “Let us permit nature to have her way. She understands her business better than we do.” – Michel de Montaigne
- “Great minds have purposes; others have wishes.” – Washington Irving
- “The great thing about getting older is that you don’t lose all the other ages you’ve been.” – Madeleine L’Engle
- “If you’re alive, there’s a purpose for your life.” – Rick Warren
- “Dream in a pragmatic way.” – Aldous Huxley
- “The works must be conceived with fire in the soul but executed with clinical coolness.” – Joan Miro
- “Memories are the key not to the past, but to the future.” – Corrie Ten Boom
- “Great minds discuss ideas; average minds discuss events; small minds discuss people.” – Eleanor Roosevelt
- “Failure will never overtake me if my determination to succeed is strong enough.” – Og Mandino
- “I think about my work every minute of the day.” – Jeff Koons
- “I restore myself when I’m alone.” – Marilyn Monroe
- “Success is peace of mind which is a direct result of self-satisfaction in knowing you did your best to become the best you are capable of becoming.” – John Wooden
- “Courage is found in unlikely places.” – J. R. R. Tolkien
- “The first wealth is health.” – Ralph Waldo Emerson
- “Courage is found in unlikely places.” – J. R. R. Tolkien
- “Do what you can, with what you have, where you are.” – Theodore Roosevelt
- “A good beginning makes a good end.” – Louis L’Amour
- “What you do today can improve all your tomorrows.” – Ralph Marston
- “One that would have the fruit must climb the tree.” – Thomas Fuller
- “Joy in looking and comprehending is nature’s most beautiful gift.” – Albert Einstein
“The future belongs to those who believe in the beauty of their dreams.” – Eleanor Roosevelt
“Never go to bed mad. Stay up and fight.” – Phyllis Diller
“The undertaking of a new action brings new strength.” – Richard L. Evans
“It’s kind of fun to do the impossible.” – Walt Disney
“Real riches are the riches possessed inside.” – B. C. Forbes
“Reject your sense of injury and the injury itself disappears.” – Marcus Aurelius
“It is not enough to have a good mind; the main thing is to use it well.” – Rene Descartes
“A leader is one who knows the way, goes the way, and shows the way.” – John C. Maxwell
“It takes an endless amount of history to make even a little tradition.” – Henry James”It’s not what you pay a man, but what he costs you that counts.” – Will Rogers
“Halloween is not only about putting on a costume, but it’s about finding the imagination and costume within ourselves.” – Elvis Duran
“Everything in the world may be endured except continual prosperity.” – Johann Wolfgang von Goethe
“Where is all the knowledge we lost with information?” – T. S. Eliot
“All I ask is the chance to prove that money can’t make me happy.” – Spike Milligan
“Out of difficulties grow miracles.” – Jean de la Bruyere
“Nine-tenths of wisdom is being wise in time.” – Theodore Roosevelt
“Time is money.” – Benjamin Franklin
“I can, therefore I am.” – Simone Weil
“Where there is no vision, there is no hope.” – George Washington Carver
“Greatness is a road leading towards the unknown.” – Charles de Gaulle
“Kind words do not cost much. Yet they accomplish much.” – Blaise Pascal
“The world is round so that friendship may encircle it.” – Pierre Teilhard de Chardin
“Our deeds determine us, as much as we determine our deeds.” – George Eliot
“The greatest use of a life is to spend it on something that will outlast it.” – William James
Happiness is not something ready made. It comes from your own actions.” – Dalai Lama
“If opportunity doesn’t knock, build a door.” – Milton Berle
“I would define, in brief, the poetry of words as the rhythmical creation of Beauty.” – Edgar Allan Poe
“There are people who have money and people who are rich.” – Coco Chanel
“The young man knows the rules, but the old man knows the exceptions.” – Oliver Wendell Holmes, Sr.
“The past always looks better than it was. It’s only pleasant because it isn’t here.” – Finley Peter Dunne
“With the new day comes new strength and new thoughts.” – Eleanor Roosevelt
“Give me the luxuries of life and I will willingly do without the necessities.” – Frank Lloyd Wright
“To begin, begin.” – William Wordsworth
“You can find peace amidst the storms that threaten you.” – Joseph B. Wirthlin
“Nobody made a greater mistake than he who did nothing because he could do only a little.” – Edmund Burke
“Whenever you find yourself on the side of the majority, it is time to pause and reflect.” – Mark Twain
“Adapt or perish, now as ever, is nature’s inexorable imperative.” – H. G. Wells
“Won’t be long before we view gasoline cars the same way we view steam engines today.” – Elon Musk
“The aim of life is to live, and to live means to be aware, joyously, drunkenly, serenely, divinely aware.” – Henry Miller
“It is not in the stars to hold our destiny but in ourselves.” – William Shakespeare“Opportunity is missed by most people because it is dressed in overalls and looks like work.” – Thomas A. Edison“Experience is one thing you can’t get for nothing.” – Oscar Wilde
“Any sufficiently advanced technology is indistinguishable from magic.” – Arthur C. Clarke
“Good questions outrank easy answers.” – Paul Samuelson
“Thinking: the talking of the soul with itself.” – Plato
“I don’t think of all the misery but of the beauty that still remains.” – Anne Frank
“All money is a matter of belief.” – Adam Smith
“People are not disturbed by things, but by the view they take of them.” – Epictetus
“Uncertainty is seen to retard investment independently of considerations of risk or expected return.” – Ben Bernanke
“I never called my work an ‘art’. It’s part of show business, the business of building entertainment.” – Walt Disney
“Hitch your wagon to a star.” – Ralph Waldo Emerson
“The greatest remedy for anger is delay.” – Lucius Annaeus Seneca
“Great minds discuss ideas; average minds discuss events; small minds discuss people.” – Eleanor Roosevelt
“Act as if what you do makes a difference. It does.” – William James
“Success – keeping your mind awake and your desire asleep.” – Walter Scott
“If I had to live my life again, I’d make the same mistakes, only sooner.” – Tallulah Bankhead
“When one must, one can.” – Charlotte Whitton
“Wealth consists not in having great possessions, but in having few wants.” – Epictetus
“If we open a quarrel between past and present, we shall find that we have lost the future.” – Winston Churchill
“Hope is patience with the lamp lit.” – Tertullian
“A single sunbeam is enough to drive away many shadows.” – Francis of Assisi
“With the past, I have nothing to do; nor with the future. I live now.” – Ralph Waldo Emerson
“Laziness may appear attractive, but work gives satisfaction.” – Anne Frank
“I never think of the future – it comes soon enough.” – Albert Einstein
Hope is but the dream of those who wake.” – Matthew Prior
“The more sand that has escaped from the hourglass of our life, the clearer we should see through it.” – Jean Paul
“Real knowledge is to know the extent of one’s ignorance.” – Confucius
“Better keep yourself clean and bright; you are the window through which you must see the world.” – George Bernard Shaw
“Nothing great in the world has ever been accomplished without passion.” – Georg Wilhelm Friedrich Hegel
“History is a vast early warning system.” – Norman Cousins
“We first make our habits, and then our habits make us.” – John Dryden
“The traveler sees what he sees, the tourist sees what he has come to see.” – Gilbert K. Chesterton
“Adventure is worthwhile.” – Aesop
“We must build dikes of courage to hold back the flood of fear.” – Martin Luther King, Jr.
“The return we reap from generous actions is not always evident.” – Francesco Guicciardini
“Courage is knowing what not to fear.” – Plato
“Science may never come up with a better office communication system than the coffee break.” – Earl Wilson
“Progress was all right. Only it went on too long.” – James Thurber
“If you would know strength and patience, welcome the company of trees.” – Hal Borland
“We aim above the mark to hit the mark.” – Ralph Waldo Emerson
“Hope is being able to see that there is light despite all of the darkness.” – Desmond Tutu
“Our chief want is someone who will inspire us to be what we know we could be.” – Ralph Waldo Emerson
“Patience is a virtue, and I’m learning patience. It’s a tough lesson.” – Elon Musk
“Great things are done when men and mountains meet.” – William Blake
“The man who has no imagination has no wings.” – Muhammad Ali
“Formula for success: rise early, work hard, strike oil.” – J. Paul Getty
“Action is the foundational key to all success.” – Pablo Picasso
“Hope is like the sun, which, as we journey toward it, casts the shadow of our burden behind us.” – Samuel Smiles
“The backbone of surprise is fusing speed with secrecy.” – Carl von Clausewitz
“There are no shortcuts in evolution.” – Louis D. Brandeis
“I am fascinated by what is beautiful, strong, healthy, what is living. I seek harmony.” – Leni Riefenstahl
“If one advances confidently in the direction of his dreams, and endeavors to live the life which he has imagined, he will meet with a success unexpected in common hours.” – Henry David Thoreau
“Waste no more time arguing about what a good man should be. Be one.” – Marcus Aurelius
“It is during our darkest moments that we must focus to see the light.” – Aristotle Onassis
“Courage is fear holding on a minute longer.” – George S. Patton
“You must be the change you wish to see in the world.” – Mahatma Gandhi
“Don’t judge each day by the harvest you reap but by the seeds that you plant.” – Robert Louis Stevenson
“It is in the character of very few men to honor without envy a friend who has prospered.” – Aeschylus
“Life is a series of natural and spontaneous changes. Don’t resist them – that only creates sorrow. Let reality be reality. Let things flow naturally forward in whatever way they like.” – Lao Tzu
“The more you praise and celebrate your life, the more there is in life to celebrate.” – Oprah Winfrey
“Anything simple always interests me.” – David Hockney
“He who angers you conquers you.” – Elizabeth Kenny
“Concision in style, precision in thought, decision in life.” – Victor Hugo
“The secret of genius is to carry the spirit of the child into old age, which means never losing your enthusiasm.” – Aldous Huxley
“View health as an investment, not an expense.” – John Quelch
“The most effective way to do it, is to do it.” – Amelia Earhart
“Man needs his difficulties because they are necessary to enjoy success.” – A. P. J. Abdul Kalam
“Do not dwell in the past, do not dream of the future, concentrate the mind on the present moment.” – Buddha
“Nobody made a greater mistake than he who did nothing because he could do only a little.” – Edmund Burke
“You must do the things you think you cannot do.”- Eleanor Roosevelt
“Success is dependent on effort.” – Sophocles
“Nobody who ever gave his best regretted it.” – George Halas
“Lots of people want to ride with you in the limo, but what you want is someone who will take the bus with you when the limo breaks down.” ~ Oprah Winfrey
“And when I breathed, my breath was lightning.” – Black Elk
“Moderation is the silken string running through the pearl chain of all virtues.” – Joseph Hall
“You are the sum total of everything you’ve ever seen, heard, eaten, smelled, been told, forgot – it’s all there. Everything influences each of us, and because of that I try to make sure that my experiences are positive.” – Maya Angelou
“If you want a guarantee, buy a toaster.” – Clint Eastwood
“We are an impossibility in an impossible universe.” – Ray Bradbury
“If you think in terms of a year, plant a seed; if in terms of ten years, plant trees; if in terms of 100 years, teach the people.” – Confucius
“I’d rather attempt to do something great and fail than to attempt to do nothing and succeed.” – Robert H. Schuller
“Do your little bit of good where you are; it’s those little bits of good put together that overwhelm the world.” Desmond Tutu
“It takes considerable knowledge just to realize the extent of your own ignorance.” – Thomas Sowell
“Do not dwell in the past, do not dream of the future, concentrate the mind on the present moment.” – Buddha”
Surprise is the greatest gift which life can grant us.” – Boris Pasternak
“Trust in dreams, for in them is hidden the gate to eternity.” – Khalil Gibran
“Always be yourself, express yourself, have faith in yourself, do not go out and look for a successful personality and duplicate it.” – Bruce Lee
“All life is an experiment. The more experiments you make the better.” – Ralph Waldo Emerson
“There are no secrets to success. It is the result of preparation, hard work, and learning from failure.” – Colin Powell
“There is more to life than increasing its speed.” – Mahatma Gandhi
“Your attitude is like a box of crayons that color your world. Constantly color your picture gray, and your picture will always be bleak. Try adding some bright colors to the picture by including humor, and your picture begins to lighten up.” – Allen Klein
“Definiteness of purpose is the starting point of all achievement.” – W. Clement Stone
“Success usually comes to those who are too busy to be looking for it.” – Henry David Thoreau
“In matters of truth and justice, there is no difference between large and small problems, for issues concerning the treatment of people are all the same.” – Albert Einstein
“Life is too short for long-term grudges.” – Elon Musk
“There cannot be a crisis next week. My schedule is already full.” – Henry Kissinger
“Success consists of getting up just one more time than you fall.” – Oliver Goldsmith
“The Earth is the cradle of humanity, but mankind cannot stay in the cradle forever.” – Konstantin Tsiolkovsky
“Ours is a world of nuclear giants and ethical infants. We know more about war that we know about peace, more about killing that we know about living.” – Omar N. Bradley
“Beauty surrounds us, but usually we need to be walking in a garden to know it.” – Rumi
“But man is not made for defeat. A man can be destroyed but not defeated.” – Ernest Hemingway
“Don’t watch the clock; do what it does. Keep going.” – Sam Levenson
“Let there be work, bread, water and salt for all.” – Nelson Mandela
“The social object of skilled investment should be to defeat the dark forces of time and ignorance which envelope our future.” – John Maynard Keynes
“A successful society is characterized by a rising living standard for its population, increasing investment in factories and basic infrastructure, and the generation of additional surplus, which is invested in generating new discoveries in science and technology.” – Robert Trout
“I know not with what weapons World War III will be fought, but World War IV will be fought with sticks and stones.” – Albert Einstein
“It is the fight alone that pleases us, not the victory.” – Blaise Pascal
“If you can’t describe what you are doing as a process, you don’t know what you’re doing.” – W. Edwards Deming
“Never interrupt your enemy when he is making a mistake.” – Napoleon Bonaparte
“Be sure you put your feet in the right place, then stand firm.” – Abraham Lincoln
“Without investment there will not be growth, and without growth there will not be employment.” – Muhtar Kent
“You have to do your own growing no matter how tall your grandfather was.” – Abraham Lincoln
“Victory has a thousand fathers, but defeat is an orphan.” – John F. Kennedy
“Delete the negative; accentuate the positive!” – Donna Karan
“It’s crazy how fast time flies and how things progress.” – Nathan Chen
“The world is a dangerous place to live; not because of the people who are evil, but because of the people who don’t do anything about it.” – Albert Einstein
“Life isn’t about finding yourself. Life is about creating yourself.” – George Bernard Shaw
“Everything has beauty, but not everyone sees it.” – Confucius
“A man must be big enough to admit his mistakes, smart enough to profit from them, and strong enough to correct them.” – John C. Maxwell
“Walking with a friend in the dark is better than walking alone in the light.” – Helen Keller
“A man who dares to waste one hour of time has not discovered the value of life.” – Charles Darwin
“The greater danger for most of us lies not in setting our aim too high and falling short; but in setting our aim too low, and achieving our mark.” – Michelangelo
“Progress is man’s ability to complicate simplicity.” – Thor Heyerdahl
“I like to encourage people to realize that any action is a good action if it’s proactive and there is positive intent behind it.” – Michael J. Fox
“Nothing is impossible, the word itself says ‘I’m possible’!” – Audrey Hepburn
“But investment in space stimulates society, it stimulates it economically, it stimulates it intellectually, and it gives us all passion.” – Bill Nye
“Bitcoin, in the short or even long term, may turn out be a good investment in the same way that anything that is rare can be considered valuable. Like baseball cards. Or a Picasso.” – Andrew Ross Sorkin
“Life is a tragedy when seen in close-up, but a comedy in long-shot.” – Charlie Chaplin
“No matter what you’re going through, there’s a light at the end of the tunnel and it may seem hard to get to it but you can do it and just keep working towards it and you’ll find the positive side of things.” – Demi Lovato
“Infrastructure investment in science is an investment in jobs, in health, in economic growth and environmental solutions.” – Oren Etzioni
“Educating our children and giving them the skills they need to compete in a global economy is a smart investment in our country’s future.” – Sheldon Whitehouse
“Know thy self, know thy enemy. A thousand battles, a thousand victories.” – Sun Tzu
“If one does not know to which port one is sailing, no wind is favorable.” – Lucius Annaeus Seneca
“Beware of missing chances; otherwise it may be altogether too late some day.” – Franz Liszt
“The sofa is a really important investment for anybody, and I don’t mean financially. You need to find a really great sofa that can transition with you, and you can build from there.” – Jeremiah Brent
“There is no investment you can make which will pay you so well as the effort to scatter sunshine and good cheer through your establishment.” – Orison Swett Marden
“Nothing in life is to be feared, it is only to be understood. Now is the time to understand more, so that we may fear less.” – Marie Curie
“There is little that can withstand a man who can conquer himself.” – Louis XIV
“In tennis, you strike a ball just after the rebound for the fastest return. It’s the same with investment.” – Masayoshi Son
“A camel makes an elephant feel like a jet plane.” – Jackie Kennedy
“The advance of technology is based on making it fit in so that you don’t really even notice it, so it’s part of everyday life.” – Bill Gates
“Success depends upon previous preparation, and without such preparation there is sure to be failure.” – Confucius, Chinese
“Coming together is a beginning; keeping together is progress; working together is success.” – Edward Everett Hale
“Never do anything against conscience even if the state demands it.”– Albert Einstein
“Education is not only a ladder of opportunity, but it is also an investment in our future.” – Ed Markey
“The true measure of a man is how he treats someone who can do him absolutely no good.” – Samuel Johnson
“In my view, the biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital. Not only is the mere drop in stock prices not risk, but it is an opportunity. Where else do you look for cheap stocks?” – Li Lu
“A successful society is characterized by a rising living standard for its population, increasing investment in factories and basic infrastructure, and the generation of additional surplus, which is invested in generating new discoveries in science and technology.” – Robert Trout
“The best preparation for tomorrow is doing your best today.” – H. Jackson Brown, Jr.
“Friendship marks a life even more deeply than love. Love risks degenerating into obsession, friendship is never anything but sharing.” – Elie Wiesel
“Investing in women’s lives is an investment in sustainable development, in human rights, in future generations – and consequently in our own long-term national interests.” – Liya Kebede
“Success isn’t measured by money or power or social rank. Success is measured by your discipline and inner peace.” – Mike Ditka
“No matter how many goals you have achieved, you must set your sights on a higher one.” – Jessica Savitch
“Start where you are. Use what you have. Do what you can.”– Arthur Ashe
“The secret of getting ahead is getting started.” – Mark Twain
“The amount of work and the amount of both physical and emotional investment it takes to get to the top.” – Drew Bledsoe
Videos
Post View Count : 501
Stay Informed. Stay Competitive.
Vista Partners offers an exclusive newsletter and content with daily, weekly, monthly and quarterly investing ideas, strategies, and marketing insights.
We value your privacy and will never share your information.
